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Abstract
Background: Hypoxic ischemia (HI) is an important cause of neonatal brain injury and subsequent inflammation affects
neurological outcome. In this study we performed investigations of systemic and local activation states of inflammatory
cells from innate and adaptive immunity at different time points after neonatal HI brain injury in mice.
Methodology/Principal Findings: We developed a multiplex flow cytometry based method combined with immunohis-
tochemistry to investigate cellular immune responses in the brain 24 h to 7 months after HI brain injury. In addition,
functional studies of ex vivo splenocytes after cerebral hypoxic ischemia were performed. Both central and peripheral
activation of CD11b
+ and CD11c
+ antigen presenting cells were seen with expression of the costimulatory molecule CD86
and MHC-II, indicating active antigen presentation in the damaged hemisphere and in the spleen. After one week, naı ¨ve
CD45rb
+ T-lymphocytes were demonstrated in the damaged brain hemisphere. In a second phase after three months,
pronounced activation of CD45rb
2 T-lymphocytes expressing CD69 and CD25 was seen in the damaged hemisphere. Brain
homogenate induced proliferation in splenocytes after HI but not in controls.
Conclusions/Significance: Our findings demonstrate activation of both local and systemic immune responses months after
hypoxic ischemic neonatal brain injury. The long term immune activation observed is of general importance for future
studies of the inflammatory response after brain injury as most previous studies have focused on the first few weeks after
damage, while the effects of the late inflammation phase may be missed. Furthermore, the self-reactive component raises
the question if there is a correlation with development of autoimmune brain disease later in life.
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Introduction
The intricate interactions of innate and adaptive immunity play
a major part in the pathology of many inflammatory conditions
and inflammation has been identified as a key factor for
neurological outcome after asphyxia. [1] Hypoxic ischemia (HI)
after asphyxia is an important cause of neonatal brain injury and
the incidence of moderate to severe hypoxic ischemic encepha-
lophathy is 0.5–2 per 1000 live births in the developed world [2]
and much more common in low income countries. [3]
Studies during the last two decades have shown that immune
cells are involved in the pathogenesis of reperfusion damage in the
brain after HI [1] [4] and the innate immune mechanisms with
cytokine effects and subsequent activation of microglia, granulo-
cytes and other innate cells have been extensively examined. [5]
Interestingly, a recent report describes activated dendritic antigen
presenting cells [6], as a possible link to adaptive immunity after
brain injury. Local T-cell infiltration has been reported in rodent
models after HI in neonates [7] and stroke in adults [8], but data
of their functional status and activation state is missing. However,
there is circumstantial evidence for a functional role of lympho-
cytes: Antibody blocking of the Very Late Antigen-4 (VLA-4),
known to block lymphocyte migration into inflamed tissue, is
protective 72 h after adult HI [9], and T- and B-cell depleted
animals have reduced infarctions 22 h after stroke in adult
animals. [10] Furthermore, depletion of regulatory T-cells, a
subpopulation with anti inflammatory properties, increases the
brain injury after ischemia [11]. These findings suggest that there
is a short term detrimental effect of adaptive immune cells, but the
long term effect is still entirely unknown. Interestingly, it was
recently shown in humans that Th1 primed activated T-cells were
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Micepresent in peripheral blood after stroke [12] and elevated levels of
antibodies against neuroantigens have also been observed in stroke
patients [13,14], which suggest induction of adaptive immune
responses.
To better understand the complex interplay between innate and
adaptive immunity after brain injury, we set out to investigate the
temporal dynamics of key immune cell populations. Markers for
principal cellular events such as antigen presentation, activation
and memory T-lymphocyte characteristics were also studied in the
brain and peripherally in the spleen. Immune cells were
characterized by multiplex flow cytometry, immunohistochemistry
and proliferation assays. Whereas previous reports have focused
on the early infiltration and inflammatory response [15], the
plausible participation of adaptive immunity implies long term
effects, why the cellular pattern was studied up to seven months
after the brain injury.
Materials and Methods
This study and all experiments were approved by the local
ethics committee, Stockholm norra djurfo ¨rso ¨ksetiska na ¨md, ethical
permit number N152/09 and carried out in accordance with local
institutional guidelines.
Animals
C57/bl6 mice (SPF) with free access to pelleted food were used
in the experiments. Pups were kept with dam at all times except
the actual surgery and hypoxia. Animals were euthanized by
injection of 240 mg/kg sodium pentobarbiturate i.p. and the tissue
was percoronarly perfused with 12 mL phosphate buffered saline
(PBS) to remove intravascular blood cells.
Hypoxic ischemic brain injury
We used a modified version of the Vannucci model [16] as
described previously [17] with unilateral electrocoagulation at 8W
of the right carotid artery via midline neck incision under
isoflourane sedation and local bupivacaine. The pups rested with
the dam 1 h after the operation, followed by 1 h of 10% O2 in
90% N2 at 36uC61uC skin temperature.
Immunohistochemistry
HI and sham operation was performed at postnatal day 10.
Brains were collected after HI at day 11 (n=3), day 12 (n=3), day
17 (n=3) and day 100 (n=3). Sham operated controls were
analyzed at day 17 (n=5). In total 17 animals were used for
immunohistochemistry. Three levels of each brain were collected,
corresponding to bregma 1.32 mm, 21.64 mm and 22.92 mm in
the adult mouse brain using cryostat 10–12 mm sections. The
tissues were fixed for 10 min in 4% paraformaldehyde. Endoge-
nous peroxidase was blocked by 0.3% H2O2 in 30% Normal
Horse Serum for 10 min and tissues incubated with antibodies
against VCAM-1, CD3 (BD Biosciences) or MAP-2 (Sigma). For
MAP-2 staining VECTORH M.O.M.
TM Immunodetection Kit
and for CD3 and VCAM-1 stainings VECTASTAINH Elite ABC-
Peroxidase Kit were used according to the manufacturers’
specifications. Pictures were recorded with a Nikon eclipse E800
light microscope with an Olympus DP70 camera with DP
controller, version 3.1.1.267 acquisition software. Percent stained
area in each hemisphere of brain slice was evaluated using Image
J, version 1.42 n.
FACS Analysis
HI was performed at postnatal day 10 and samples were
analyzed at day 11 (n=6), day 12 (n=7), day 13 (n=7), day 17
(n=6), day 24 (n=6), day 100 (n=7) and day 200 (n=3). Sham
operated controls were analyzed day 11 (n=3), day 17 (n=3) and
day 200 (n=5). Unoperated animals were analyzed at day 17
(n=6) and day 100 (n=3). For a schematic time-line see
Figure 1A. In total 62 animals were used for FACS analysis.
Statistical power analysis was performed on pilot data (n=3 per
group) 1 week after HI, not included in further analyses in this
study. Cells from the damaged and undamaged brain hemispheres
and spleen were prepared as follows: Brains were collected and
prefrontal part and cerebellum were removed. The spleen,
damaged and undamaged hemisphere of the brain were put in
ice-cold RPMI-1640 medium. Samples were homogenized with a
glass homogenizer and filtered through a 100 mm celltainer filter.
Spleen cell suspensions were hemolyzed with ACK-buffer
(0.15 mol/L NH4Cl, 1 mmol/L KHCO3, 0.1 mmol/L EDTA
and H2O, pH 7.2) for 5 min and washed in PBS. Samples were
spun at 3006g, cells incubated with anti-CD16/32 Fc-receptor
block for 10 min and washed in FACS buffer (2% BGS, 0.1%
NaN3 in PBS) before surface staining. In this study we omitted any
density gradient or enzymatic digestion steps used in other studies
[8,18] to avoid any selection bias, loss of cells, modification to
surface marker expression or cell function that has previously been
reported in comparative methodological studies [19,20,21].
Samples were stained with antibodies, for details on markers
and target cell populations see Methods S1 (table S1); TCR-b
APC-Cy7 and I-Ab PE from Biolegend, as well as Ly-6G FITC,
CD8a PerCP-Cy5.5, CD86 APC, CD11b APC-Cy7, CD11c PE-
Cy7, CD4 APC, CD45rb PE from BD Pharmingen, and DAPI.
Flow cytometric data was collected on a FACSAria (BD
Biosciences) and analyzed using the FACSDiva software. Gates
were set by investigators blinded to treatment and time point.
Approximately 2.5610
6 events were analyzed from each brain
hemisphere and 1610
6 cells from each spleen, reported as positive
per million live cells (DAPI
2). The cell content after HI brain
injury was compared to sham or unoperated controls. For FACS
analysis, gates were set to filter out debris in forward and side
scatter, with a negative DAPI gate to exclude dead cells. Gates
were set on histograms from positive and negative controls for
each separate experiment. The same gates were used on all
samples run simultaneously on both spleen and brain, including
controls and operated animals when applicable.
Proliferation assay
Thymidine incorporation based proliferation assays were
performed as previously described [22], using brain homogenate
as stimuli and PBS as negative control n=4 for each group.
Single-cell suspensions of splenocytes were prepared from un-
operated, age-matched controls 3 and 5 months after HI as
described for flow cytometry, and dissolved in RPMI-1640 with
10% BGS, 1% PeSt, 1% Glutamine, 50 mM 2-ME, and 1%
Pyruvate. 3–4610
5 cells per well were added to 96-well plates and
stimulated with brain homogenate or PBS. Brain homogenate was
prepared from damaged/undamaged brain, homogenized in
5 mL RPMI-1640, and kept at 220uC. For stimulation, brain
homogenate was added at a ratio of 1:100. Plates were kept at
37uC for two to six days, pulsed with 1 mCi/well [
3H]Thymidine
for 18 h and frozen at 220uC. Plates were thawed and well
content transferred to a glass fibre filter (Wallac) by a cell harvester
(TOMTEC). For detection of radioactivity, Meltilex A – Melt on
scintillation sheets (Wallac) were used and radioactivity was
measured in a 1205 Betaplate Liquid Scintillation Counter
(Wallac). Proliferation index was calculated as: cpm(brain homog-
enate)/cpm(PBS).
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All statistical analysis used Statistica 8.0 from Statsoft. Inc.
Factorial Anova was used with Tukey or Dunnett post-hoc test
when appropriate.
Results
To better understand inflammation after HI in the neonatal
brain, we investigated different immune cell populations from
innate and adaptive immunity after acute unilateral infarction in
the immature brain. No significant differences were seen between
sham operated animals (24 h and 1 week after the skin incision)
and age matched controls, indicating that brain immune cell
content can be regarded as relatively stable during unchallenged
conditions, unaffected by sham operation. Therefore both
unoperated and sham operated animals were used as baseline
controls to calculate p-values, the groups and SEM are however
presented separately in the graphs. Loss of MAP-2 staining by
immunohistochemistry was used to visualize a typical lesion
(Figure 1B).
Immune response in the brain
We developed a multiplex flow cytometry based method for
investigation of cellular immune responses after brain HI. To
minimize the influence from ex vivo procedures, cells were
promptly analyzed without any further purification steps or
procedures except immunostaining. For reproducible results;
debris and aggregates were filtered out, DAPI used to exclude
dead cells, a high number of events collected and a strict gating
strategy applied. Known splenetic cell populations were used as
reference to validate the gating strategy in brain.
Initially there was a rapid activation of innate CD11b
+ cells as
judged by upregulation of the costimulatory molecule CD86 (B7.2)
in the injured hemisphere after HI (Figure 1C). The initial
activation wave at 24 h was followed by a second increase of
activated CD11b
+CD86
+ cells, with the maximum peak at one
week after the insult, succeeded by a return to normal levels after
two weeks (Figure 1C). The number of CD11c
+ cells and Ly-6G
+
granulocytes increased in both hemispheres 24 to 48 hours after
HI (data not shown). However, the activation of CD11c
+ cells
increased significantly after 48 h only in the damaged hemisphere,
followed by a second wave of activated CD11c
+CD86
+ cells
observed after one week (Figure 1C). MHC-II expression in
CD11b
+ cells increased 24 h after injury, returned to normal levels
after 48 h and later increased again after three months (Figure 1D).
In contrast, CD11c
+ cells first displayed significant upregulation of
MHC-II at three months after brain damage (Figure 1D).
We also investigated the activation and recruitment of T-cells.
Initially, sections from mice with HI brain injury were stained with
an antibody against the pan T-cell marker CD3. As demonstrated
in Figure 2A, the unaffected hemisphere contained no detectable
infiltrates two weeks after the injury, whereas the infarcted area
contained substantial infiltrates of CD3
+ T-lymphocytes. Subse-
quently, we performed temporal FACS analysis of T-lymphocyte
influx into both hemispheres after HI brain injury on individual
mice (Figure 2B). The initial influx of CD4
+ T-lymphocytes
peaked one week after HI with a more than three-fold increase
compared to baseline. Interestingly, the initial CD4
+ influx into
the affected hemisphere was followed by recruitment of CD8
+
cytotoxic T-cells, peaking two weeks after HI.
The T-cells entering the injured hemisphere after one week
expressed the naı ¨ve T-cell marker [23] CD45rb (Figure 2C). To
our surprise, we found a significant number of naı ¨ve CD8
+ T-
lymphocytes entered the undamaged hemisphere after two weeks,
whereas no entrance of naı ¨ve CD4
+ T-cells was demonstrated in
the undamaged hemisphere (Figure 2C, left). The number of naı ¨ve
CD45rb expressing CD4
+ and CD8
+ cells returned to normal
within three months.
In addition, we stained T-lymphocytes for expression of the very
early activation marker [24] CD69 and the IL-2 receptor a-chain
(CD25). The expression of CD69 and CD25 increased both in
CD4
+ and CD8
+ populations reaching maximum levels three
months after HI brain injury (Figure 2D). A subpopulation of
CD4
+CD8
+ double positive T-cells, not seen in controls, appeared
in the damaged brain at three months (Figure 3A and 3B), but
disappeared again at seven months. Furthermore, the T-cells
which infiltrated the brain three months after HI were mainly
CD4
+CD45rb
low (Figure 2B, C).
Immune response in the spleen
In parallel, we investigated the immune response in the
periphery by flow cytometry of splenocytes from HI brain injured
animals. Firstly, the HI induced peripheral effects on splenic
macrophages and dendritic cells were investigated. There was an
initial rapid ten-fold increase in number of CD11b expressing cells
(Figure 4A) accompanied by an five-fold increase in Ly-6G
+
granulocytes (data not shown), already after 24 h. These
populations returned to normal after one week. The initial
increase in CD11b expressing cells was followed by an activation
phase after one week as determined by the increased expression of
the costimulatory molecule CD86 (Figure 4A, right). Initially,
there were no significant differences in the number of CD11c
+
cells in the spleen after HI brain damage, but at three months a
transitory increase was observed (Figure 4B). In addition, there
was an increase in the proportion activated CD86 expressing
CD11c
+ dendritic cells from one week to three months after injury
(Figure 4B, right).
We next set out to investigate if the increased activation of
peripheral antigen presenting cells in the spleen after HI brain
injury resulted in activation of the adaptive immune system. The
HI injured mice demonstrated a brief activation of CD8
+ T-
lymphocytes in the spleen at one week measured by a significant
increase in the very early activation marker CD69 expression
(Figure 4C). At three months after induced brain injury, a second
more pronounced activation peak of both CD4
+ and CD8
+ T-
lymphocytes was observed (Figure 4C). Notably, a CD4
+CD8
+
double positive population first appeared briefly after 24 h,
returned at two weeks and remained significantly increased up
to three months after brain HI (Figure 3C).
Functional status
To clarify the implications of the peripheral activation of
splenocytes after HI brain injury, we performed functional
stimulation tests. Recall assays three and five months after injury,
Figure 1. Local innate inflammatory cell response after hypoxic ischemic (HI) brain injury. (A) Time-line with experimental setup. (B)
Representative cross-section of MAP-2 (live neurons) stained mouse brain two weeks after brain damage. (C) Number of CD11b
+ (left) and CD11c
+
cells (right) expressing the activation marker CD86 over time. (D) Number of CD11b
+ (left) and CD11c
+ cells (right) expressing MHC-II (H2IAb) over
time. Red circle=infarcted hemisphere, black triangle=uninjured hemisphere, blue diamond=sham operated, and green square=unoperated.
*=p,0.05, **=p,0.01 and ***=p,0.001. Compared to sham and unoperated controls. Error bars represent SEM.
doi:10.1371/journal.pone.0036422.g001
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increase in proliferation index of splenic T-cells from brain injured
compared to sham operated mice (Figure 5A). The proliferation
was increased to a similar extent when homogenate from infarcted
hemisphere, undamaged hemisphere, unoperated control brain or
spinal cord was used (data not shown).
Homing to the brain
Next, we investigated a possible mechanism of T-lymphocyte
homing to the brain by immunohistochemistry using antibodies
against Vascular Cell Adhesion Molecule 1 (VCAM-1). Increased
VCAM-1 expression was observed in the infarcted area of the
injured brain hemisphere and associated blood vessels (Figure 5B),
to a significant degree from one to two weeks after injury
(Figure 5C) with a tendency towards increased expression after
three months. In addition, there was a slight increase of VCAM-1
expression in the non-injured brain hemisphere, although not
significant (Figure 5B).
Figure 2. Local T-cell response after hypoxic ischemic (HI) brain injury. (A) T-lymphocytes infiltrating injured (right) and uninjured (left)
hemisphere, visualized by anti-CD3 immunohistochemistry. Ruler indicates 200 mm. (B) CD4
+ (left) and CD8
+ (right) T-lymphocyte infiltrating cells per
10
6 live cells after HI brain injury (C) the expression of the naı ¨vety marker CD45rb, and (D) the activation markers CD69 and CD25 in these
populations. Open red circle=infarcted hemisphere, black triangle=uninjured hemisphere, blue square=sham operated and green filled
circle=unoperated.
doi:10.1371/journal.pone.0036422.g002
Figure 3. Presence of double-positive CD4
+CD8
+ T-cells after hypoxic ischemic brain injury. (A) CD4
+ and CD8
+ T-lymphocytes in
unoperated age matched control (left) and damaged brain hemisphere (right) two weeks after HI. Note the double positive population marked in red.
(B) Proportion CD4
+CD8
+ double positive T-lymphocytes in brain and (C) spleen after HI. Red circle=infarcted hemisphere (B) or HI (C), black
triangle=uninjured hemisphere, blue diamond=sham operated, and green square=unoperated.
doi:10.1371/journal.pone.0036422.g003
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Using multiplex flow cytometry we describe key events in
cellular immune infiltration and activation after aseptic brain
hypoxic ischemia in neonate mice. We visualized, both in the post
ischemic brain and systemically, the infiltration and activation of
innate antigen presenting cells and for the first time, the sequential
activation of T-lymphocytes. The flow cytometric data are
supported by ex vivo functional data demonstrating self-reactivity
with a lymphocyte response stimulated by brain antigens five
months after HI brain injury.
Activation of antigen presenting cells
The first immune activation observed after HI consisted of brain
CD11b
+ cells and has previously been recognized as foremost
microglia, in contrast to the second activation peak after one week
which mainly consists of infiltrating macrophages. [25] The early
activation of CD11c
+CD86
+ cells is also in agreement with earlier
reports. [6] Interestingly, CD11b
+ microglial cells significantly
increased their MHC-II expression after 24 h, and cerebral
CD11b
+ and CD11c
+ cells three months after HI (Figure 1D),
thereby allowing interactions between APCs and T-cells.
A recent report by Hug et al describes reduced stimulatory
capacity of circulating APCs three days after injury in an adult
stroke model [26]. Interestingly, these results correspond well with
our finding that peripheral APCs show a tendency toward reduced
CD86 expression compared to controls during the first few days
after HI (Figure 4A–B). Notably however, starting one week after
HI, an extensive increase in the proportion of CD86 expressing
CD11b
+ and CD11c
+ cells was seen which persisted at three
Figure 4. Systemic inflammatory cell response after hypoxic ischemic (HI) brain injury. (A) CD11b
+ cells per 10
6 live cells in the spleen
over time after HI brain injury (left) and the CD86
+ proportion of these cells (right). (B) CD11c
+ cells per 10
6 live cells (left) and the CD86
+ proportion of
these cells (right). (C) CD4
+ and CD8
+ T-lymphocytes expressing the activation markers CD69 and CD25 in spleen. Red circle=HI, green
diamond=sham operated, and blue square=unoperated.
doi:10.1371/journal.pone.0036422.g004
Figure 5. Splenocyte proliferation and VCAM-1 expression in brain after hypoxic ischemic brain injury. (A) Proliferation index of
splenocytes from mice three and five months after HI or sham operation measured by [
3H] Thymidine incorporation after stimulation with brain
extract. (B) VCAM-1 expression in the infarcted hippocampus region (star) and blood vessels (arrow) as visualized by immunohistochemistry. Ruler
indicates 500 mm. (C) VCAM-1 expression in damaged (squares) and undamaged (circles) hemispheres over time after HI brain injury.
doi:10.1371/journal.pone.0036422.g005
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(Figure 4A–B). Microglial cells have a common progenitor with
monocytes and share CD11b and CD11c markers [27]. Our
results indicate that brain HI activates antigen presenting cells
originating from the brain and bone marrow. Furthermore, our
data clearly demonstrates systemic activation of antigen presenting
cells (APCs) alongside the local brain responses.
Induction of adaptive immunity
The increase of CD86
+ and MHC-II expressing APCs in the
brain after HI suggests preparation for activation of adaptive
immune responses. In adult stroke models, T-lymphocytes have
been increasingly implicated in the pathophysiology following
stroke [28,29] and it is apparent that the local inflammatory
response is accompanied by massive systemic effects [30]. We
therefore investigated recruitment and activation of T-lympho-
cytes. Although there have been earlier reports of T-cell
infiltration, hitherto the functional status of infiltrating lympho-
cytes after brain injury has been unknown and there has been
some controversy in the literature regarding what population of T-
lymphocytes dominate after brain injury [7,31]. Our data
demonstrates that the initial influx of T-lymphocytes was
dominated by CD4
+ T-helper cells, followed one week later by
CD8
+ cytotoxic T-cells (Figure 2A), where the temporal profiles
could explain the previous discrepancy.
The significant upregulation of VCAM-1 in the damaged
hemisphere one week after the insult (Figure 5B and 5C) suggests
recruitment of lymphocytes. VCAM/VLA-4 interactions have
been demonstrated to play a major role in lymphocyte trafficking
to the brain after stroke in adult animals [32]. Strikingly, in our
model VCAM-1 expression correlates perfectly in time with the
appearance of brain infiltrating T-lymphocytes at one week.
The T-cells entering the injured brain hemisphere one week
after HI expressed the naı ¨ve T-cell marker CD45rb, but three
Figure 6. Local and peripheral dynamics of innate and adaptive immune activation after hypoxic ischemic brain injury. (A) Temporal
correlation of activated cells after HI brain injury. Note the 24 h and one week activation of CD11b
+ cells as well as brain T-cell infiltration after one
week. Black filled line; activated CD11b
+CD86
+ cells in the brain. Green short dashed line; activated CD8
+CD69
+ and blue long dashed line;
CD4
+CD69
+ T-lymphocytes in the brain. Red dotted line; activated splenetic T-lymphocytes. Yellow long dashed line; Proportion CD86 expressing
splenetic APCs. (B) Schematic overview of cellular inflammation after HI brain injury.
doi:10.1371/journal.pone.0036422.g006
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+ cells were seen (Figure 2C). The
diminished number of CD45rb expressing cells could either be due
to efflux of lymphocytes or activation and maturation. [23] Since
the number of infiltrating lymphocytes is not affected (Figure 2B)
the data suggests that the T-cells remain in the brain, become
activated and down-regulate the expression of CD45rb. To test
this hypothesis we stained T-lymphocytes for the activity markers
CD69 and CD25 and could indeed demonstrate a prolonged
activation in the brain (Figure 2D). Gelderblom et al reported early
brain T-cell infiltration up to one week after adult mouse stroke,
but found no significant changes in activation status. [8] This is
mainly in agreement with our results, where the activation of T-
lymphocytes was first detectable one week after HI, with the
highest activation levels observed three months after damage. The
differences seen could be explained by both the model used and/
or the age of animals as well as differences in methodology prior to
flow cytometric analysis. To our knowledge this is the first report
of activated T-cells in the brain after HI.
T-lymphocyte characteristics coherent with self reactivity
The activation of T-cells after an aseptic insult raises the
question whether the late phase activation is recognizing self, and
thus is part of an autoimmune reaction against damaged brain
tissue. Intriguingly, the subpopulation of CD4
+CD8
+ double
positive T-lymphocytes appearing in the damaged brain and
spleen post HI (Figure 3), has in the human setting been linked to
different autoimmune diseases. [33] In the autoimmune disorder
multiple sclerosis (MS), circulating CD4
+CD8
+ T-lymphocytes has
been found to increase [34], be pathogenic and infiltrate the CNS.
[35] Moreover, the T-lymphocytes which infiltrated the brain
three months after HI were mainly CD4
+CD45rb
low (Figure 2C), a
cell population which infiltrates the CNS in the murine model of
MS, experimental allergic encephalomyelitis (EAE) [36]. Activated
peripheral T-cells recognizing brain antigens as well as elevated
autoantibody levels towards neuroantigens have been observed in
humans after stroke [13,14,37], and it has been speculated that
this may influence the development of stroke related dementia in
adults [13]. In clinical data, there is increasing evidence for a
relation between fetal/neonatal infection/inflammation and neu-
rodevelopmental impairments such as cerebral palsy. [38] One
could therefore speculate that the long term clinical manifestations
after brain HI would present as immune mediated neurodevelop-
mental disorders rather than well-established autoimmune diseases
such as MS.
Functional implications
Interestingly, brain homogenate was able to stimulate prolifer-
ation in the post HI splenocytes whereas cells from sham operated
animals did not respond. Since brain tissue is not immunogenic
during normal conditions the increased proliferation is most likely
due to an antigen specific, long-lived peripheral activation of T-
cells following brain injury. In this context, the report of activated
peripheral T-lymphocytes in humans after stroke is intriguing. [12]
Since the cellular immune responses after HI brain injury varied
less than the damage size seen in previous studies, the clinical
outcome is probably not only dependent on the degree of immune
activation but also on which antigens are targeted and the cytokine
milieu. The actual antigens involved, clonality and function of the
responding T-lymphocytes warrant further investigation.
Summary
In conclusion, our results converge to form a dynamic temporal
model of both central and peripheral, innate and adaptive
immune activation after HI brain injury (Figure 6). The observed
downregulation of CD45rb in brain infiltrating cells in combina-
tion with an activated phenotype after three months and
peripheral responsiveness to brain homogenate is intriguing. The
persistent activation even months after injury stresses the need for
long-term follow-up, since late phase events otherwise will be
missed. Peripheral activation of brain recognizing T-cells may lead
to an increased risk of autoreactive brain damage later in life at
time points where the blood brain barrier permits entrance of T-
lymphocytes e.g. infections. Since some neurodevelopmental
disorders, such as autism spectrum disorders, have been linked
to immune activation and dysregulation [39,40], it is possible that
neurodevelopmental impairments in children after HI encepha-
lopathy could be partly explained by latent inflammation. Further
studies are needed in order to clarify the role and interactions of
innate and adaptive immunity after HI brain injury. Understand-
ing the basic functions and temporal interactions of these cells will
pave the road for new immunomodulatory therapeutic strategies
and are a vital prerequisite for the optimal timing of such
treatments.
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